Papers - Sugimoto, Yoshikazu
-
A novel yeast cell-based screening identifies flavone as a tankyrase inhibitor.
Yashiroda Y, Okamoto R, Hatsugai K, Takemoto Y, Goshima N, Saito T, Hamamoto M, Sugimoto Y, Osada H, Seimiya H, Yoshida M*.
Biochem Biophys Res Commun 394(3) 569-573 2010.03
Research paper (scientific journal), Joint Work, Accepted
-
Breast cancer resistance protein (BCRP) is a molecular determinant of the outcome of photodynamic therapy (PDT) for centrally located early lung cancer.
Usuda J*, Tsunoda Y, Ichinose S, Ishizumi T, Ohtani K, Maehara S, Ono S, Tsutsui H, Ohira T, Okunaka T, Furukawa K, Sugimoto Y, Kato H, Ikeda N.
Lung Cancer 67 198-204 2010.02
Research paper (scientific journal), Joint Work, Accepted
-
Dofequidar fumarate sensitizes cancer stem-like side population cells to chemotherapeutic drugs by inhibiting ABCG2/BCRP-mediated drug export.
Katayama R, Koike S, Sato S, Sugimoto Y, Tsuruo T, Fujita N*.
Cancer Sci 100 2060-2068 2009.11
Research paper (scientific journal), Joint Work, Accepted
-
Environmental contamination due to preparation of cyclophosphamide and exposure of pharmacists to it.
Hama T*, Aoyama T, Shirai T, Higuchi S, Yokokawa T, Sugimoto Y.
Jpn J Pharm Health Care Sci 35(10) 693-700 2009.09
Research paper (scientific journal), Joint Work, Accepted
-
Substrate-dependent bidirectional modulation of P-glycoprotein-mediated drug resistance by erlotinib.
Noguchi K, Kawahara H, Kaji A, Katayama K, Mitsuhashi J, Sugimoto Y*.
Cancer Science 100 1701-1707 2009.09
Research paper (scientific journal), Joint Work, Accepted
-
Acyl-CoA synthetase as a cancer survival factor: its inhibition enhances the efficacy of etoposide.
Mashima T, Sato S, Okabe S, Miyata S, Matsuura M, Sugimoto Y, Tsuruo T, Seimiya H*.
Cancer Sci 100 1556-1562 2009.08
Research paper (scientific journal), Joint Work, Accepted
-
CMC-544 (inotuzumab ozogamicin), an anti-CD22 immuno-conjugate of calicheamicin, alters the levels of target molecules of malignant B-cells.
Takeshita A*, Yamakage N, Shinjo K, Ono T, Hirano I, Nakamura S, Shigeno K, Tobita T, Maekawa M, Kiyoi H, Naoe T, Ohnishi K, Sugimoto Y, Ohno R.
Leukemia 23 1329-136 2009.07
Research paper (scientific journal), Joint Work, Accepted
-
CMC-544 (inotuzumab ozogamicin) shows less effect on multidrug resistant cells: analyses in cell lines and cells from patients with B-cell chronic lymphocytic leukemia and lymphoma.
Takeshita A*, Shinjo K, Yamakage N, Ono T, Hirano I, Matsui H, Shigeno K, Nakamura S, Tobita T, Maekawa M, Ohnishi K, Sugimoto Y, Kiyoi H, Naoe T, Ohno R.
Br J Haematol 146 34-43 2009.06
Research paper (scientific journal), Joint Work, Accepted
-
Pharmacological interplay between breast cancer resistance protein and gefitinib in epidermal growth factor receptor signaling.
Katayama K, Shibata K, Mitsuhashi J, Noguchi K, Sugimoto Y.
Anticancer Reserch 29 ( 4 ) 1059-1065 2009.04
Research paper (scientific journal), Joint Work, Accepted
-
Identification of cytochrome P450s required for fumitoremorgin biosynthesis in Aspergillus fumigatus.
Kato, N, Suzuki H, Takagi H, Asami Y, Kakeya H, Uramoto M, Usui T, Takahashi S, Sugimoto Y, Osada H*.
Chembiochem 10 920-928 2009.03
Research paper (scientific journal), Joint Work, Accepted
-
Identification of cytochrome P450s required for fumitremorgin biosynthesis in Aspergillus fumigatus.
Kato, N, Suzuki H, Takagi H, Asami Y, Kakeya H, Uramoto M, Usui T, Takahashi S, Sugimoto Y, Osada H.
Chembiochem: a European journal of chemical biology 10 ( 5 ) 920-928 2009.03
Research paper (scientific journal), Single Work, Accepted
-
Promotion of glioma cell survival by acyl-CoA synthetase 5 under extracellular acidosis conditions.
'Mashima T, Sato S, Sugimoto Y, Tsuruo T, Seimiya, H*.'
Oncogene 28 ( 1 ) 9-19 2009.01
Research paper (scientific journal), Joint Work, Accepted
-
Functions of breast cancer resistance protein (BCRP/ABCG2) in chemotherapy.
'Noguchi K, Katayama K, Mitsuhashi J, Sugimoto Y*.'
Advanced Drug Delivery Reviews (/Elsevier) 61 26-33 2009.01
Research paper (scientific journal), Joint Work, Accepted
-
Pharmacological Interplay between breast cancer resistance protein and gefitinib in epidermal growth factor receptor signaling.
Katayama K, Shibata K, Mitsuhashi J, Noguchi K, Sugimoto Y*.
Anticancer Research 29 1059-1065 2009.01
Research paper (scientific journal), Joint Work, Accepted
-
CMC-544 (inotuzumab ozogamicin) shows less effect on multidrug resistant cells: analyses in cell lines and cells from patients with B-cell chronic lymphocytic leukemia and lymphoma.
Takeshita A, Shinjo K, Yamakage N, Ono T, Hirano I, Matsui H, Shigeno K, Nakamura S, Tobita T, Maekawa M, Ohnishi K, Sugimoto Y, Kiyoi H, Naoe T, Ohno R.
British journal of haematology 146 34-43 2009
Research paper (scientific journal), Joint Work, Accepted
-
CMC-544 (inotuzumab ozogamicin), an anti-CD22 immuno-conjugate of calicheamicin, alters the levels of target molecules of malignant B-cells.
Takeshita A, Yamakage N, Shinjo K, Ono T, Hirano I, Nakamura S, Shigeno K, Tobita T, Maekawa M, Kiyoi H, Naoe T, Ohnishi K, Sugimoto Y, Ohno R.
Leukemia 2009
Research paper (scientific journal), Single Work, Accepted
-
Acyl-CoA synthetase as a cancer survival factor: its inhibition enhances the efficacy of etoposide.
Mashima T, Sato S, Okabe S, Miyata S, Matsuura M, Sugimoto Y, Tsuruo T, Seimiya H.
Cancer Science 2009
Research paper (scientific journal), Joint Work, Accepted
-
Breast cancer resistance protein (BCRP) is a molecular determinant of the outcome of photodynamic therapy (PDT) for centrally located early lung cancer.
Usuda J, Tsunoda Y, Ichinose S, Ishizumi T, Ohtani K, Maehara S, Ono S, Tsutsui H, Ohira T, Okunaka T, Furukawa K, Sugimoto Y, Kato H, Ikeda N.
Lung Cancer 2009
Research paper (scientific journal), Joint Work, Accepted
-
Substrate-dependent bidirectional modulation of P-glycoprotein-mediated drug resistance by erlotinib.
Noguchi K., Kawahara H, Kaji A, Katayama K, Mitsuhashi J, Sugimoto Y.
Cancer Science 2009
Research paper (scientific journal), Joint Work, Accepted
-
標的タンパク質・標的酵素の遺伝子多型と薬剤感受性.
杉本芳一.
腫瘍内科 (/科学評論社) 2(2) 136-144 2008.04
Research paper (scientific journal), Single Work, Accepted